Tyler Benedum has served as Aktis Oncology's Chief Technical Officer since May 2024, having joined the company in January 2022 as Senior Vice President, CMC. From 2005 to 2022 he held positions of increasing seniority at Avid Radiopharmaceuticals (acquired by Eli Lilly and Company), most recently as Vice President of CMC Development and Manufacturing. He received a BS in Chemistry from Washington College and a PhD in Organic Chemistry from the University of Virginia.